「臺北榮民總醫院」為長聖國際生技合作醫療院所之一，於2025年11月25日獲衛福部核准「自體免疫細胞（gamma-delta T）」治療「實體癌第四期」之細胞治療，為符合收治條件的病人進行相關治療療程，其適應症為：實體癌第四期；癌症別：乳癌、肺癌、大腸直腸癌、腎細胞癌、攝護腺癌、胃癌。
Taipei Veterans General Hospital, one of the medical institutions cooperating with Ever-Supreme, received approval from the Ministry of Health and Welfare on November 25, 2025, for "autologous immune cell (gamma-delta T)" cell therapy to treat "stage IV solid cancer". It provides related treatment courses for patients who meet the admission criteria. The indications are: stage IV solid cancer; cancer types: breast cancer, lung cancer, colorectal cancer, renal cell carcinoma, prostate cancer, and gastric cancer.
